Paragon Associates & Paragon Associates II Joint Venture Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACW
PacWest Bancorp
PACW
|
+$7.94M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$4.92M |
| 3 |
Occidental Petroleum
OXY
|
+$4.57M |
| 4 |
Goldman Sachs
GS
|
+$4.51M |
| 5 |
Delta Air Lines
DAL
|
+$3.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$11.1M |
| 2 |
Par Pacific Holdings
PARR
|
+$2.22M |
| 3 |
AAT
American Assets Trust
AAT
|
+$602K |
| 4 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$580K |
| 5 |
CF Industries
CF
|
+$280K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 23.96% |
| 2 | Healthcare | 22.16% |
| 3 | Financials | 13.06% |
| 4 | Industrials | 7.8% |
| 5 | Technology | 2.98% |
Similar funds
Paragon Associates & Paragon Associates II Joint Venture's Q3 2017 Portfolio in Review
As of Q3 2017, Paragon Associates & Paragon Associates II Joint Venture held 25 positions worth $117M, up 33% from $88.1M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Paragon Associates & Paragon Associates II Joint Venture deployed $15.5M of net new capital in Q3 2017, opening 10 new positions and adding to 2 existing holdings. Its largest new stake was PacWest Bancorp: 169,681 shares worth $8.57M.
By sector, the portfolio is most concentrated in Energy at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $11.1M trimmed.
- Paragon Associates & Paragon Associates II Joint Venture's largest Q3 2017 buy was PacWest Bancorp: 169,681 shares worth $8.57M.
- Paragon Associates & Paragon Associates II Joint Venture added most to Citigroup in Q3 2017, an estimated $683K increase.
- Paragon Associates & Paragon Associates II Joint Venture's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $11.1M.
- Paragon Associates & Paragon Associates II Joint Venture fully exited Entellus Medical, Inc. Common Stock in Q3 2017, selling an estimated $580K.
- Paragon Associates & Paragon Associates II Joint Venture's ten largest holdings make up 75% of its $117M portfolio in Q3 2017.
- Paragon Associates & Paragon Associates II Joint Venture opened 10 new positions and closed 2 in Q3 2017.
- Paragon Associates & Paragon Associates II Joint Venture's portfolio value rose 33% quarter-over-quarter to $117M.
Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q3 2017, filed 13 Nov 2017.